XenoPort has received a US patent for, prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use. The patent is directed to composition and formulations of the XP23829 compound and another patent ...
Tags: XenoPort, US patent, covering composition
Acetylon Pharmaceuticals has received US patent covering fundamental composition of matter claims of the selective HDAC6 inhibitor, ACY-1215. ACY-1215T is at present being investigated in human trials to treat multiple myeloma. ...
Tags: US Patent, multiple myeloma, drug